Ethnic pharmacological relevance Anxiety or depression after percutaneous coronary
intervention (PCI) is a common clinical disease. Currently, conventional pharmacotherapy …

Aims: The objective of this study was to assess the efficacy and potential mechanisms of
Chinese herbal medicine (CHM) for treating coronary heart disease (CHD) patients with …

Objective To evaluate the effectiveness and safety of oral Chinese herbal medicines (CHMs)
on post-percutaneous coronary intervention (PCI) patients with depressive disorder in …

Background With the increasing pressures of modern life and work, combined with a
growing older population, the incidence of comorbid anxiety and myocardial infarction (MI) is …

OBJECTIVE: To evaluated the effectiveness and safety of Chinese herbal medicines (CHMs)
for coronary heart disease (CHD) complicated with anxiety. METHODS: Randomized …

Background: It's known that coronary heart disease (CHD) patients after percutaneous
coronary intervention (PCI) was significantly associated with anxiety and depression …

Objective. The purpose of this study is to assess the efficacy and safety of the integration of
Western medicine with traditional Chinese medicine (TCM) in patients with coronary heart …

Background Xinkeshu tablets (XKS), a well-known Chinese patent drug, have been
administered to coronary heart disease (CHD) patients with anxiety and depression after …

Coronary heart disease (CHD) poses a significant threat to human life and well‐being. The
presence of psycho‐cardiology diseases not only exacerbates the progression of CHD but …

Background: Percutaneous coronary intervention (PCI) has been increasingly applied as an
effective revascularization strategy in patients with coronary artery disease (CAD). However …